Michigan beat Michigan State football 24-17 the 2024 edition of the rivalry. Check out the recap and highlights.

(MARQUETTE COMMUNICATIONS) MILWAUKEE – The Marquette University women’s volleyball team hits the road for three matches on ...

The Courant’s arts picks for Oct. 20-26 include Halloween-themed theater productions, ’80s and ’90s hitmakers and a spate of ...

It's hosted state high school football finals, NCAA track and field championships, the Chicago Bears games and the very first ...

“We’re not going to let her destroy our country like she did San Francisco ... some election analysts and pollsters told The Hill this week it could have an effect in a handful of important ...

A hearing was held Tuesday in downtown San Diego to discuss the potential release of Alvin Quarles, a convicted rapist known for his brutal crimes in the 1980s. Dubbed the “Bolder Than Most ...

He's a go for Sunday, per head coach Brian Callahan. "Will will start," Callahan said. "No surprise there. He had a good week of practice, felt good. "He threw well (in practice), and is looking good, ...

Any opportunity to chuckle during any given episode of this dark show is welcome. This week, Ghost Cameron (Linden Ashby) was on a roll. He called Chance (Conner Floyd) “Detective Dreamy ...

Shares of Sudarshan Chemical Industries rallied 20 per cent on Friday, October 11 to their 52-week high after the company announced the acquisition of the global pigment business of Germany’s ...

Last week in LA, Cooper had his most productive outing to date despite playing only 38 percent of the defensive snaps, finishing with five tackles, a sack, and two QB hits. This week, Cooper could see ...

Ruchit Jain, Lead Research Analyst at 5paisa, highlighted that the immediate near-term hurdle for the Divi's Laboratories share price is around ₹6,150 as per retracements. If the stock manages ...

The fund just hit a 52-week high and moved up 31.8% from its 52-week low price of $29.50/share. Are more gains in store for this ETF? Let us take a quick look at the fund and the near-term outlook ...